Page results
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
-
Latest news and developments in the Macmillan Support and Information Service
-
Information about staff who work in the Macmillan Support and Information Service.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
Health and wellbeing information for people affected by cancer.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Bones marrow harvest patient information page.
File results
-
FOI/2024/0277 - Paediatric respiratory admission rates 2018-2023
-
FOI/2024/0279 - Social media management platforms and tools
-
FOI/2024/0283 - Cyber security/ cyber attack
-
FOI/2024/0285 - Private patient non-contractual tariffs
-
FOI/2024/0288 - Maternity ward closure for new admissions 2019-2023
-
FOI/2024/0291 - Private patient income 2020-2023
-
FOI/2024/0295 - MRI scanners at Trust 2019/2020 and 2022/24
-
FOI/2024/0297 - Policy for parasitic infestation assessment and treatment of patients
-
FOI/2024/0301 - Nursing associates and trainee nursing associates policy
-
FOI/2024/0302 - Mental health diagnosis for patients aged 11 to 25